Aminologics Co.,Ltd. (KOSDAQ:074430)
1,387.00
-57.00 (-3.95%)
At close: Apr 30, 2026
Aminologics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 26,456 | 18,882 | 11,999 | 12,738 | 8,861 |
Short-Term Investments | 26,500 | 16,500 | 16,500 | 16,500 | 16,500 |
Trading Asset Securities | 10,076 | - | - | - | 302.04 |
Cash & Short-Term Investments | 63,032 | 35,382 | 28,499 | 29,238 | 25,663 |
Cash Growth | 78.14% | 24.15% | -2.53% | 13.93% | 1.10% |
Accounts Receivable | 7,465 | 4,498 | 8,241 | 5,384 | 6,334 |
Other Receivables | 249.38 | 151.8 | 175.94 | 260.15 | 155.36 |
Receivables | 7,714 | 4,650 | 8,417 | 5,644 | 6,489 |
Inventory | 4,440 | 6,083 | 7,977 | 8,335 | 6,373 |
Prepaid Expenses | 150 | 213.72 | 189.9 | 285.58 | 83.86 |
Other Current Assets | 3,274 | 188.02 | 166.43 | 66.39 | 69.7 |
Total Current Assets | 78,610 | 46,517 | 45,249 | 43,569 | 38,679 |
Property, Plant & Equipment | 2,612 | 3,090 | 2,630 | 2,826 | 2,120 |
Long-Term Investments | 714.11 | 3,905 | 4,988 | 4,368 | 5,101 |
Other Intangible Assets | 1,998 | 3,046 | 4,054 | 4,074 | 17,598 |
Long-Term Deferred Tax Assets | - | - | 515.44 | 520.95 | 1,522 |
Other Long-Term Assets | 244.02 | 231.23 | 231.48 | 224.05 | 221.75 |
Total Assets | 84,178 | 56,789 | 57,668 | 55,582 | 65,243 |
Accounts Payable | 837.74 | 2,459 | 648.71 | 1,550 | 3,674 |
Accrued Expenses | 320.1 | 288.89 | 247.74 | 207.15 | 159.36 |
Short-Term Debt | 15,449 | 1,000 | 1,000 | 1,000 | 1,000 |
Current Portion of Leases | 196.13 | 283.66 | 229.42 | 239.59 | 185.74 |
Other Current Liabilities | 10,773 | 310.79 | 541.65 | 431.99 | 362.01 |
Total Current Liabilities | 27,576 | 4,342 | 2,668 | 3,429 | 5,381 |
Long-Term Leases | 569.02 | 734.77 | 589.53 | 749.49 | 468.03 |
Long-Term Unearned Revenue | 39.53 | 17.12 | - | - | - |
Other Long-Term Liabilities | -0 | -0 | - | 0 | - |
Total Liabilities | 28,185 | 5,094 | 3,257 | 4,178 | 5,849 |
Common Stock | 8,783 | 8,783 | 8,783 | 8,783 | 8,783 |
Additional Paid-In Capital | 118,400 | 118,400 | 118,400 | 118,400 | 118,400 |
Retained Earnings | -69,772 | -73,997 | -72,377 | -74,814 | -67,532 |
Comprehensive Income & Other | -1,417 | -1,490 | -394.49 | -965.24 | -257.89 |
Shareholders' Equity | 55,994 | 51,695 | 54,411 | 51,404 | 59,393 |
Total Liabilities & Equity | 84,178 | 56,789 | 57,668 | 55,582 | 65,243 |
Total Debt | 16,214 | 2,018 | 1,819 | 1,989 | 1,654 |
Net Cash (Debt) | 46,817 | 33,364 | 26,680 | 27,249 | 24,010 |
Net Cash Growth | 40.32% | 25.05% | -2.09% | 13.49% | 1.29% |
Net Cash Per Share | 531.78 | 370.70 | 303.78 | 310.26 | 273.38 |
Filing Date Shares Outstanding | 88.68 | 87.83 | 87.83 | 87.83 | 87.83 |
Total Common Shares Outstanding | 88.68 | 87.83 | 87.83 | 87.83 | 87.83 |
Working Capital | 51,034 | 42,175 | 42,581 | 40,140 | 33,298 |
Book Value Per Share | 631.45 | 588.61 | 619.53 | 585.29 | 676.25 |
Tangible Book Value | 53,996 | 48,649 | 50,357 | 47,330 | 41,795 |
Tangible Book Value Per Share | 608.91 | 553.92 | 573.36 | 538.90 | 475.88 |
Land | 281.84 | 281.84 | 281.84 | 281.84 | 281.84 |
Buildings | 840.38 | 840.38 | 840.38 | 840.38 | 840.38 |
Machinery | 7,622 | 7,584 | 7,033 | 6,864 | 6,349 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.